SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-192929
Filing Date
2022-07-13
Accepted
2022-07-13 16:34:55
Documents
15
Period of Report
2022-07-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d367256d8k.htm   iXBRL 8-K 26333
2 EX-99.1 d367256dex991.htm EX-99.1 25537
6 GRAPHIC g367256g0712222355393.jpg GRAPHIC 5972
7 GRAPHIC g367256g0712222355994.jpg GRAPHIC 1497
  Complete submission text file 0001193125-22-192929.txt   189617

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rprx-20220713.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20220713_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20220713_pre.xml EX-101.PRE 10818
9 EXTRACTED XBRL INSTANCE DOCUMENT d367256d8k_htm.xml XML 3298
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 221081372
SIC: 2834 Pharmaceutical Preparations